Study details
Enrolling now
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Center for International Blood and Marrow Transplant Research
NCT IDNCT00785525ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
60,000
Study length
about 33 years
Ages
18–60
Locations
4 sites in FL, MD, MN +1
What this study is about
This trial is testing a treatment to collect stem cells from healthy volunteers using filgrastim. The goal is to evaluate the safety of this process and determine if it's acceptable for unrelated donor hematopoietic stem cell transplant recipients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Filgrastim
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Injection / IV
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
filgrastim
Drug routes
injection (Injection)